Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-12
2007-06-12
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S326000, C514S422000, C514S423000, C544S141000, C546S208000, C548S518000, C548S561000
Reexamination Certificate
active
11155764
ABSTRACT:
5-aminomethyl-1H-pyrrole-2-carboxylic acid amide compounds corresponding to formula Iand processes for the production thereof. Pharmaceutical preparations containing these compounds and the use of these compounds for the production of pharmaceutical preparations and in related treatment methods.
REFERENCES:
patent: 3551571 (1970-12-01), Pachter et al.
patent: 6849730 (2005-02-01), Lindsey et al.
patent: WO 02/02521 (2002-01-01), None
patent: WO 02/057253 (2002-07-01), None
Chakraborty, et al., Development of 5-(aminomethyl)pyrrole-2-carboxylic acid as a constrained surrogate of Gly-ΔAla and its appplication in peptidomimetic studies. Tetrahedron Letters 43 (2002) 2589-2592.
Scott, et al., Piperazinylalkyl Heterocycles as Potential Antipsychotic Agents. J. Med. Chem. 38 (1995) 4198-4210.
Oliver H. Lowry et al., “Protein Measurement with the Folin Phenol Reagent”, May 28, 1951, pp. 265-275, Washington University School of Medicine, Department of Pharmacology, St. Louis, Missouri, USA.
Martin Ch. Frink et al., “Influence of Tramadol on Neurotransmitter Systems of the Rat Brain”, Arzneim-Forsch./ Drug Res., 1996, pp. 1029-1036, vol. 46 (III), Nr. 11.
L.C. Hendershot et al., “Antagonism of the Frequency of Phenylquinone-Induced Writing in the Mouse by Weak Analgesics and Nonanalgesics”, Sep. 19, 1958, pp. 237-240, vol. 125, The Biomedical Research Laboratory, The Dow Chemical Company, Midland, Michigan, USA.
E.G. Gray et al., “The Isolation of Nerve Endings from Brain: An Electron-Microscopic Study of Cell Fragments Derived by Homogenization and Centrifugation”, Journal of Anatomy, pp. 79-88, vol. 96, Part 1 (1962).
Andrew J. Carpenter et al., The Scope and Limitations of Carboxamide-Induced β- Directed Metalation of 2-Substituted Furan, Thiophene, and 1-Methylpyrrole Derivatives. Application of Method to Syntheses of 2,3-Disubstituted Thiophenes and Furans, J. Org. Chem., 1985, pp. 4362-4368, vol. 50, No. 22, American Chemical Society.
Beatrix Merla et al., “Efficient Synthesis of γ-Oxo- and γ-Hydroxy-α-amino Acids”, Synthesis, Nov. 1998, pp. 1609-1614.
von Claudia Betschart et al., “Scope and Limitations of the Reductive Coupling of Aromatic Aldimine Derivatives with Formation of 1,2-Diarylethylenediame Units, Using Low-Valent Titanium Regeants”, Helvetica Chimica Acta, 1988, pp. 1999-2023, vol. 71.
Mark A. Longer et al., “Sustained-Release Drug Delivery Systems”, pp. 1644-1661, Chapter 92, (1985).
Stuart C. Porter, PH.D, “Coating of Pharmaceutical Dosage Forms”, pp. 1633-1643, Chapter 91 (1985).
Robert E. King, PH.D et al, “Oral Solid Dosage Forms”, pp. 1603-1632, Chapter 90 (1985).
Edward G. Ripple, Ph.D., “Powders”, pp. 1585-1602, Chapter 89 (1985).
Lawrence H. Block, PH.D., Medicated Applications, pp. 1567-1584, Chapter 88 (1985).
John D. Mullins, PH.D., “Ophthalmic Preparations”, pp. 1553-1566, Chapter 87 (1985).
Salvatore J. Turco, Pharm.D et al., “Intravenous Admixtures”, pp. 1542-1552, Chapter 86 (1985).
Kenneth E. Avis, DSC, “Parenteral Preparations”, pp. 1518-1541, Chapter 85 (1985).
J. G. Narin, PH.D., “Solutions, Emulsions, Suspensions and Extractives”, pp. 1492-1517, Chapter 84 (1985).
Clyde R. Erskine, Jr, “Quality Assurance and Control”, pp. 1487-1491, Chapter 83 (1985).
Carl J. Lintner, PH.D., “Stability of Pharmaceutical Products”, pp. 1478-1486, Chapter 82 (1985).
Robert L. Giles, B.A. et al., “Plastic Packaging Materials”, pp. 1473-1477, Chapter 81 (1985).
Frederick P. Siegel, PH.D., “Tonicity, Osmoticity, Osmolality, and Osmolarity”, pp. 1455-1472, Chapter 80 (1985).
G. Briggs Phillips, PH.D., “Sterilization”, pp. 1443-1454, Chapter 79 (1985).
Adelbert M. Knevel, PH.D., “Separation”, pp. 1432-1442, Chapter 79 (1985).
Anthony R. Disanto, PH.D., “Bioavailability and Bioequivalency Testing”, pp. 1424-1431, Chapter 77 (1985).
Englberger Werner
Hennies Hagen-Heinrich
Jagusch Utz-Peter
Kögel Babette-Yvonne
Merla Beatrix
Crowell & Moring LLP
Freistein Andrew B.
Gruenenthal GmbH
Saeed Kamal A.
LandOfFree
Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3854121